Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
Completed · Phase 2
Conditions studied: Lymphoproliferative Disorder
In brief
RATIONALE: Drugs used in chemotherapy such as cyclophosphamide, prednisone, and methylprednisolone use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Combining cyclophosphamide and either prednisone or methylprednisolone with rituximab may be effective in treating lymphoproliferative disease following organ transplantation. PURPOSE: Phase II trial to study the effectiveness of combining cyclophosphamide and either prednisone or methylprednisolone with rituximab in treating patients who have Epstein-Barr virus-positive lymphoproliferative disease following organ transplantation.
Key facts
- Study ID
- NCT00066469
- Run by
- Children's Oncology Group
- People needed
- 55
- Starts
- 2004-04-01
- Expected to finish
- 2013-12-31
- Last updated by the study team
- 2019-08-06
Who can join
Age: any, up to 30. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Phoenix Children's Hospital — Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Southern California Permanente Medical Group — Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center — Loma Linda, California, United States
- Kaiser Permanente Medical Center - Oakland — Sacramento, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Stanford Cancer Center — Stanford, California, United States
- Children's Hospital Center for Cancer and Blood Disorders — Aurora, Colorado, United States
- Alfred I. duPont Hospital for Children — Wilmington, Delaware, United States
- Lee Cancer Care of Lee Memorial Health System — Fort Myers, Florida, United States
- University of Florida Shands Cancer Center — Gainesville, Florida, United States
- Nemours Children's Clinic — Jacksonville, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami — Miami, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital — Pensacola, Florida, United States
- All Children's Hospital — St. Petersburg, Florida, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- University of Illinois Cancer Center — Chicago, Illinois, United States
- Children's Memorial Hospital - Chicago — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Simmons Cooper Cancer Institute — Springfield, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
- Kosair Children's Hospital — Louisville, Kentucky, United States
- Tulane Cancer Center Office of Clinical Research — Alexandria, Louisiana, United States
- C.S. Mott Children's Hospital at University of Michigan Medical Center — Ann Arbor, Michigan, United States
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.